articleThe LancetJun 1, 2003Closed access

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,898
total citations
FWCI
238.63
Percentile
100%
References
54
Citations per year

Authors

6

Topics & keywords

Keywords
  • Medicine
  • Simvastatin
  • Diabetes mellitus
  • Myocardial infarction
  • Internal medicine
  • Placebo
  • Stroke (engine)
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.